Although CKD is recognized as a risk factor for the development of active TB [1, 7], evidence in the literature regarding its association with LTBI remains limited. This is particularly due to the heterogeneity in cohort study designs, the…
Use of interferon-gamma release assay (IGRA) and CXCL-10/IP-10 for latent tuberculosis infection (LTBI) screening in chronic kidney disease and hemodialysis patients | BMC Infectious Diseases
